Cargando…
[6]-Gingerol-Derived Semi-Synthetic Compound SSi6 Inhibits Tumor Growth and Metastatic Dissemination in Triple-Negative Breast Cancer Xenograft Models
SIMPLE SUMMARY: Triple-negative breast cancers (TNBC) represent approximately 15% of all breast cancers and lack the expression of a defined molecular target. This absence makes this subtype of cancer difficult to treat and control. Current chemotherapy drugs cause various side effects and toxicitie...
Autores principales: | Luna-Dulcey, Liany, Almada da Silva, James, Jimenez-Renard, Veronica, Caleiras, Eduardo, Mouron, Silvana, Quintela-Fandino, Miguel, Cominetti, Marcia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228746/ https://www.ncbi.nlm.nih.gov/pubmed/34201040 http://dx.doi.org/10.3390/cancers13122855 |
Ejemplares similares
-
Autophagy-dependent apoptosis is triggered by a semi-synthetic [6]-gingerol analogue in triple negative breast cancer cells
por: Luna-Dulcey, Liany, et al.
Publicado: (2018) -
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
por: Mouron, Silvana, et al.
Publicado: (2021) -
[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo
por: Martin, Ana Carolina B.M., et al.
Publicado: (2017) -
Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach
por: Bueno, Maria J, et al.
Publicado: (2017) -
Monitoring vascular normalization: new opportunities for mitochondrial inhibitors in breast cancer
por: Mouron, Silvana, et al.
Publicado: (2021)